Okugawa Y, et al. - In patients with gastric cancer (GC), researchers evaluated the clinical feasibility of the newly developed lymphocyte-to-C-reactive protein (CRP) ratio (LCR) and lymphocyte CRP score (LCS) for predicting short- and long-term outcomes. From 551 GC patients, they retrospectively analyzed pre-operative LCRs and LCSs to clarify the prognostic ability for overall survival (OS) and disease-free survival (DFS) and to clarify the predictive ability for peri-operative risk of surgical site infection in GC patients. In these patients, pre-operative LCR and LCS are clinically feasible nutrition-inflammation markers. Lymphocyte assessment and CRP could assist doctors in determining surgical risk and oncological risk, thereby facilitating adequate peri-operative and post-operative management of GC patients